We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
-25.13%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$808M
AUM Growth
-$138M
Cap. Flow
+$114M
Cap. Flow %
14.08%
Top 10 Hldgs %
50%
Holding
73
New
21
Increased
14
Reduced
9
Closed
24

Top Buys

Rank Stock Value
1
ZAYO
Zayo Group Holdings, Inc.
ZAYO
+$46.9M
2
VTRS icon
Viatris
VTRS
+$32.7M
3
RDUS
Radius Health, Inc.
RDUS
+$30.7M
4
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
+$29.4M
5
CHRS icon
Coherus Oncology
CHRS
+$28M

Top Sells

Rank Stock Value
1
MDR
McDermott International
MDR
+$27.1M
2
CZR
Caesars Entertainment Corporation
CZR
+$22.7M
3
FLXN
Flexion Therapeutics, Inc.
FLXN
+$22.1M
4
GMS
GMS Inc
GMS
+$20.5M
5
BLDR icon
Builders FirstSource
BLDR
+$18.3M

Sector Composition

Rank Sector Weight
1 Healthcare 36.37%
2 Financials 17.17%
3 Technology 9.55%
4 Consumer Discretionary 7.08%
5 Materials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMS
26
DELISTED
GMS Inc
GMS
$12.5M 1.55%
841,716
-1,166,676
-58% -$20.5M
OSG
27
Octave Specialty Group
OSG
$205M
$12.2M 1.52%
710,433
-689,567
-49% -$12.7M
FG
28
DELISTED
FGL Holdings Ordinary Shares
FG
$10.3M 1.27%
1,543,873
+670,071
+77% +$5.2M
MGY icon
29
Magnolia Oil & Gas
MGY
$6.16B
$8.32M 1.03%
742,477
– –
FLXN
30
DELISTED
Flexion Therapeutics, Inc.
FLXN
$8.13M 1.01%
718,307
-1,406,693
-66% -$22.1M
BDSI
31
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$7.38M 0.91%
+1,995,959
New +$7.01M
NTRA icon
32
Natera
NTRA
$45.1B
$7.34M 0.91%
525,805
+200,000
+61% +$3.65M
PRSP
33
DELISTED
Perspecta Inc. Common Stock
PRSP
$6.86M 0.85%
+398,080
New +$8.82M
CNDT icon
34
Conduent
CNDT
$245M
$6.09M 0.75%
573,295
-326,705
-36% -$5.09M
AKBA icon
35
Akebia Therapeutics
AKBA
$240M
$5.92M 0.73%
1,070,095
+767,364
+253% +$6.01M
TXMD icon
36
TherapeuticsMD
TXMD
$24M
$5.89M 0.73%
+30,905
New +$7.54M
CBT icon
37
Cabot Corp
CBT
$4.49B
$4.61M 0.57%
+107,301
New +$5.35M
RYAM.PRA
38
DELISTED
Rayonier Advanced Materials Inc. 8.00% Series A Mandatory Convertible Preferred Stock
RYAM.PRA
$3.84M 0.48%
46,620
-3,600
-7% -$358K
HWM icon
39
CALL
Howmet Aerospace
HWM
$112B
$3.37M 0.42%
+260,800
New +$4.08M
RVI
40
DELISTED
Retail Value Inc. Common Shares
RVI
$2.6M 0.32%
1,108,943
– –
CLLS
41
Cellectis
CLLS
$291M
$1.99M 0.25%
+119,465
New +$2.77M
OEC icon
42
Orion
OEC
$377M
$1.88M 0.23%
+74,416
New +$1.94M
TPCO
43
DELISTED
Tribune Publishing Company Common Stock
TPCO
$1.73M 0.21%
152,201
– –
EAGLW
44
DELISTED
Platinum Eagle Acquisition Corp. Warrant
EAGLW
$845K 0.1%
+650,000
New +$937K
BERY
45
DELISTED
Berry Global Group, Inc.
BERY
$505K 0.06%
+11,567
New +$494K
PLYA
46
DELISTED
Playa Hotels & Resorts
PLYA
$471K 0.06%
+65,502
New +$531K
MAS icon
47
Masco
MAS
$15B
$418K 0.05%
+14,299
New +$444K
LH icon
48
Labcorp
LH
$26.1B
$371K 0.05%
+3,415
New +$457K
ATRS
49
DELISTED
Antares Pharma, Inc.
ATRS
$35K ﹤0.01%
+12,865
New +$42.4K
AMPY icon
50
Amplify Energy
AMPY
$186M
– –
-165,000
Closed -$1.47M
1
2
3

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
IAA
Independent Advisor Alliance Charlotte, North Carolina $9.32B AUM 33.19% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return

Rubric Capital Management (New York)'s Q4 2018 Portfolio in Review

As of Q4 2018, Rubric Capital Management (New York) held 73 positions worth $808M, down 15% from $946M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Rubric Capital Management (New York) deployed $114M of net new capital in Q4 2018, opening 21 new positions and adding to 14 existing holdings. Its largest new stake was Zayo Group Holdings, Inc.: 1,713,800 shares worth $39.1M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, up from 20% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Flexion Therapeutics, Inc., an estimated $22.1M trimmed.

  • Rubric Capital Management (New York)'s largest Q4 2018 buy was Zayo Group Holdings, Inc.: 1,713,800 shares worth $39.1M.
  • Rubric Capital Management (New York) added most to Radius Health, Inc. in Q4 2018, an estimated $30.7M increase.
  • Rubric Capital Management (New York)'s biggest Q4 2018 reduction was Flexion Therapeutics, Inc., cutting an estimated $22.1M.
  • Rubric Capital Management (New York) fully exited McDermott International in Q4 2018, selling an estimated $27.1M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 50% of its $808M portfolio in Q4 2018.
  • Rubric Capital Management (New York) opened 21 new positions and closed 24 in Q4 2018.
  • Rubric Capital Management (New York)'s portfolio value fell 15% quarter-over-quarter to $808M.

Based on Rubric Capital Management (New York)'s 13F filing for Q4 2018, filed 13 Feb 2019.